These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35053434)

  • 21. Biodistribution and radiation dosimetry of [
    Hohberg M; Kobe C; Krapf P; Täger P; Hammes J; Dietlein F; Zlatopolskiy BD; Endepols H; Wild M; Neubauer S; Heidenreich A; Neumaier B; Drzezga A; Dietlein M
    EJNMMI Res; 2019 Jul; 9(1):66. PubMed ID: 31346821
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Dong S; Li Y; Chen J; Li Y; Yang P; Li J
    Front Oncol; 2022; 12():1025930. PubMed ID: 36568229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent Updates on Molecular Imaging Reporting and Data Systems (MI-RADS) for Theranostic Radiotracers-Navigating Pitfalls of SSTR- and PSMA-Targeted PET/CT.
    Werner RA; Thackeray JT; Pomper MG; Bengel FM; Gorin MA; Derlin T; Rowe SP
    J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31331016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Interobserver Agreement on PSMA PET/CT Even in the Absence of Clinical Data.
    Bundschuh RA; Lütje S; Bundschuh L; Lapa C; Higuchi T; Hartrampf PE; Gorin MA; Kosmala A; Buck AK; Pomper MG; Rowe SP; Essler M; Sheikh GT; Werner RA
    Clin Nucl Med; 2023 Mar; 48(3):207-212. PubMed ID: 36723879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interobserver agreement of [
    Derwael C; Lavergne O; Lovinfosse P; Nechifor V; Salvé M; Waltregny D; Hustinx R; Withofs N
    EJNMMI Res; 2020 Feb; 10(1):15. PubMed ID: 32112230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of volumetric parameters based on
    Li Y; Chen J; Wang X; Yang P; Yang J; Zhao Q; Li J
    Front Oncol; 2024; 14():1335205. PubMed ID: 38469242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reliability of gradient-based segmentation for measuring metabolic parameters influenced by uptake time on 18F-PSMA-1007 PET/CT for prostate cancer.
    Lau YC; Chen S; Ho CL; Cai J
    Front Oncol; 2022; 12():897700. PubMed ID: 36249043
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Zhou S; Liu T; Zhu Z; Zhang L; Qian S; Fu H; Cao Q; Kang J
    Front Oncol; 2022; 12():800904. PubMed ID: 35186741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlations of the
    Karyagar SS; Karyagar S; Guven O
    Hell J Nucl Med; 2020; 23(2):120-124. PubMed ID: 32716402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative evaluation of PSMA PET imaging using a realistic anthropomorphic phantom and shell-less radioactive epoxy lesions.
    Fedrigo R; Kadrmas DJ; Edem PE; Fougner L; Klyuzhin IS; Petric MP; Bénard F; Rahmim A; Uribe C
    EJNMMI Phys; 2022 Jan; 9(1):2. PubMed ID: 35032234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic Performance of [
    Paymani Z; Rohringer T; Vali R; Loidl W; Alemohammad N; Geinitz H; Langsteger W; Beheshti M
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32708097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interobserver and intraobserver agreement on prostate-specific membrane antigen PET/CT images according to the miTNM and PSMA-RADS criteria.
    Demirci E; Akyel R; Caner B; Alan-Selçuk N; Güven-Meşe Ş; Ocak M; Kabasakal L
    Nucl Med Commun; 2020 Aug; 41(8):759-767. PubMed ID: 32453205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solitary rib lesions showing prostate-specific membrane antigen (PSMA) uptake in pre-treatment staging
    Chen MY; Franklin A; Yaxley J; Gianduzzo T; McBean R; Wong D; Tatkovic A; McEwan L; Walters J; Kua B
    BJU Int; 2020 Sep; 126(3):396-401. PubMed ID: 32592330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced Segmentation of Lesions Is Comparable to Whole-Body Segmentation for Response Assessment by PSMA PET/CT: Initial Experience with the Keyhole Approach.
    Hartrampf PE; Krebs M; Peter L; Heinrich M; Ruffing J; Kalogirou C; Weinke M; Brumberg J; Kübler H; Buck AK; Werner RA; Seitz AK
    Biology (Basel); 2022 Apr; 11(5):. PubMed ID: 35625388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lesion-to-background ratio threshold value of SUVmax of simultaneous [
    Zhao J; Hamm B; Brenner W; Makowski MR
    Insights Imaging; 2020 Dec; 11(1):137. PubMed ID: 33331959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-Center Comparison of [
    Mirzaei S; Lipp R; Zandieh S; Leisser A
    Curr Oncol; 2021 Oct; 28(5):4167-4173. PubMed ID: 34677271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of early imaging with
    Özülker F
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(2):100-105. PubMed ID: 30514659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of hybrid (68)Ga-PSMA PET/MRI and (68)Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer.
    Freitag MT; Radtke JP; Hadaschik BA; Kopp-Schneider A; Eder M; Kopka K; Haberkorn U; Roethke M; Schlemmer HP; Afshar-Oromieh A
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):70-83. PubMed ID: 26508290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined Early and Late [
    Hohberg M; Kobe C; Täger P; Hammes J; Schmidt M; Dietlein F; Wild M; Heidenreich A; Drzezga A; Dietlein M
    Mol Imaging Biol; 2019 Jun; 21(3):558-566. PubMed ID: 30105521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pilot study comparing dominant intraprostatic lesion volume using Ga-68 prostate-specific membrane antigen PET-computed tomography and multiparametric MRI.
    Sasidharan A; Murthy V; Natarajan A; Agarwal A; Ranagrajan V; Gudi S; Singh S; Popat P
    Nucl Med Commun; 2020 Dec; 41(12):1291-1298. PubMed ID: 32941400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.